Other languages Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
10.3 ^USD	-3.47%		-8.61%	-19.22%

Mar. 25	Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	MT
Feb. 27	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	Mar. 25
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	Feb. 27
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes	Feb. 02
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	Feb. 02
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million	Jan. 08
Sector Update: Health Care Stocks Advance Premarket Friday	Nov. 10
Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook	Nov. 10
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023	Nov. 09
Treace Medical Concepts, Inc. Highlights New Product Innovations and Updated Align3d Clinical Study Data At the American Orthopaedic Foot & Ankle Society Annual Meeting 2023	23-09-20
Treace Medical Concepts, Inc. Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures	23-09-11
Treace Medical Concepts, Inc. Appoints Nathan Minnich as Senior Vice President, Marketing	23-08-21
Treace Medical Concepts Q2 Adjusted Loss Narrows, Revenue Rises; 2023 Revenue Outlook Lifted	23-08-09
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023	23-08-08
Treace Medical Concepts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Treace Medical Concepts, Inc. Appoints Julie Dewey as Chief Communications and Investor Relations Officer, Effective July 17, 2023	23-07-12
Treace Medical Concepts, Inc. completed the acquisition of certain assets of MIOS Marketing, LLC.	23-06-11
Insider Sell: Treace Medical Concepts	23-06-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Other languages

Filters